Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Objective Our aim was to assess the real‐world effectiveness of immune checkpoint
inhibitors for treatment of patients with progressive multifocal leukoencephalopathy (PML) …

Acquired demyelinating diseases of the central nervous system (CNS) comprise
inflammatory conditions, including multiple sclerosis (MS) and related diseases, as well as …

L'ouvrage-Devenu un «classique» dès sa première édition, l'Abrégé de neurologie
présente, de façon claire, pratique et complète, les troubles neurologiques selon une …

The high efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis
(MS) is without controversy. Indeed, effective disease control was not only demonstrated in …

Progressive multifocal leukoencephalopathy (PML) is a rare but fatal opportunistic infection
and mainly occurs in patients with immunosuppressive conditions. Despite the increasing …

Employing a long-time series of municipal wastewater samples collected in 2020, the
present study aims to confirm whether the appearance of SARS-CoV-2 influences the …

Progressive multifocal leukoencephalopathy (PML) is an opportunistic demyelinating
disease leading to disability or being sometimes fatal, and it is caused by the reactivation of …

Introduction Progressive Multifocal Leukoencephalopathy (PML) is a rare and deadly
demyelinating disease caused by JC virus (JCV) replication in the central nervous system …

Multiple sclerosis (MS) was defined as a rare disease in China due to its low prevalence. For
a long time, interferon β was the only approved disease-modifying therapy (DMT). Since the …